These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9357411)

  • 41. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Down detection.
    Ezzell C
    Sci Am; 1998 Nov; 279(5):28-9. PubMed ID: 9796544
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of first trimester maternal serum and ultrasound screening for Down's syndrome in Eastern and Northern Finland.
    Niemimaa M; Suonpää M; Perheentupa A; Seppälä M; Heinonen S; Laitinen P; Ruokonen A; Ryynänen M
    Eur J Hum Genet; 2001 Jun; 9(6):404-8. PubMed ID: 11436120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome.
    Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Buytaert P
    Hum Reprod; 1998 Mar; 13(3):744-8. PubMed ID: 9572446
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
    Reynolds TM; Aldis J
    Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 47. Down's syndrome screening using free beta hCG: instability can significantly increase the Down's risk estimate.
    Beaman JM; Akhtar N; Goldie DJ
    Ann Clin Biochem; 1996 Nov; 33 ( Pt 6)():525-9. PubMed ID: 8937583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
    Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
    Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal screening for Down's syndrome.
    Gocze PM; Arany A; Freeman DA
    N Engl J Med; 1992 Dec; 327(27):1951; author reply 1952-3. PubMed ID: 1280772
    [No Abstract]   [Full Text] [Related]  

  • 51. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First-trimester Down syndrome screening in renal-transplanted pregnant women: a model for adjusting the false-positives rates.
    Grande M; Cararach V; Casals E; Borrell A
    Prenat Diagn; 2013 May; 33(5):467-70. PubMed ID: 23505023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contingent triple-screening for Down syndrome in the second trimester is not a cost-effective prenatal screening strategy in Mainland Chinese population.
    Li DZ
    Prenat Diagn; 2010 May; 30(5):493. PubMed ID: 20440741
    [No Abstract]   [Full Text] [Related]  

  • 54. Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
    Ogueh O
    Br J Obstet Gynaecol; 1995 Apr; 102(4):349-50. PubMed ID: 7542022
    [No Abstract]   [Full Text] [Related]  

  • 55. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
    Palomaki GE; Neveux LM; Haddow JE
    J Med Screen; 1996; 3(1):12-7. PubMed ID: 8861045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What factors regulate HCG production in Down's syndrome pregnancies?. Screening for Down's syndrome using HCG concentrations - a common practice but still an enigma.
    Goshen R
    Mol Hum Reprod; 1999 Oct; 5(10):893-5. PubMed ID: 10508214
    [No Abstract]   [Full Text] [Related]  

  • 57. Antenatal screening for Down's syndrome.
    Spencer K; Macri JN; Coombes EJ; Ward AM
    BMJ; 1993 Jun; 306(6892):1616. PubMed ID: 7687179
    [No Abstract]   [Full Text] [Related]  

  • 58. Risk estimation in Down's syndrome screening.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1996 Nov; 16(11):1055-7. PubMed ID: 8953642
    [No Abstract]   [Full Text] [Related]  

  • 59. [Trisomy-21 screening using AFPplus in the eastern part of Switzerland].
    Zimmermann R; Schmid W; Binkert F; Achermann J; Huch R; Huch A
    Schweiz Med Wochenschr; 1995 Jul; 125(26):1286-93. PubMed ID: 7541552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation of an antenatal serum screening programme for Down's syndrome in two districts (Brighton and Eastbourne). The Brighton and Eastbourne Down's Syndrome Screening Group.
    Piggott M; Wilkinson P; Bennett J
    J Med Screen; 1994 Jan; 1(1):45-9. PubMed ID: 8790485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.